Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

This study has been completed.
Sponsor:
Information provided by:
Canadian Cancer Trials Group
ClinicalTrials.gov Identifier:
NCT00002866
First received: November 1, 1999
Last updated: November 7, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: No date given